Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert J Cote

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Endocrine-Related Cancer|May 29, 2020
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Early thyroidectomy in multiple endocrine neoplasia: a four decade experienceElizabeth G Grubbs, Ronald M Lechan, Beth Edeiken-Monroe, et al.
Oncotarget|April 30, 2016
Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma modelBrian P Danysh, Erin Y Rieger, Deepankar K Sinha, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2009
Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalaciaMouhammed Amir Habra, Camilo Jimenez, Su-Chen Eileen Huang, et al.
Journal of Pediatric Surgery|April 15, 2014
Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of pediatric patients with primary hyperparathyroidismMinerva A Romero Arenas, Lilah F Morris, Thereasa A Rich, et al.
Thyroid : Official Journal of the American Thyroid Association|November 7, 2017
Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid CancerAnisley Valenciaga, Elizabeth G Grubbs, Kyle Porter, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 7, 2002
Genotype-phenotype analysis in multiple endocrine neoplasia type 1Maria A Kouvaraki, Jeffrey E Lee, Suzanne E Shapiro, et al.
BMC Genomics|May 14, 2008
Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arraysHannah C Cheung, Keith A Baggerly, Spiridon Tsavachidis, et al.
Surgery|December 6, 2011
Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are importantPaxton V Dickson, Thereasa A Rich, Yan Xing, et al.
Hormones & Cancer|June 18, 2016
Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer CenterIoannis Christakis, Wei Qiu, Angelica M Silva Figueroa, et al.
Thyroid : Official Journal of the American Thyroid Association|July 21, 2005
RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumorsMaria A Kouvaraki, Suzanne E Shapiro, Nancy D Perrier, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Endocrine-Related Cancer|May 29, 2020
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Early thyroidectomy in multiple endocrine neoplasia: a four decade experienceElizabeth G Grubbs, Ronald M Lechan, Beth Edeiken-Monroe, et al.
Oncotarget|April 30, 2016
Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma modelBrian P Danysh, Erin Y Rieger, Deepankar K Sinha, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2009
Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalaciaMouhammed Amir Habra, Camilo Jimenez, Su-Chen Eileen Huang, et al.
Journal of Pediatric Surgery|April 15, 2014
Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of pediatric patients with primary hyperparathyroidismMinerva A Romero Arenas, Lilah F Morris, Thereasa A Rich, et al.
Thyroid : Official Journal of the American Thyroid Association|November 7, 2017
Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid CancerAnisley Valenciaga, Elizabeth G Grubbs, Kyle Porter, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 7, 2002
Genotype-phenotype analysis in multiple endocrine neoplasia type 1Maria A Kouvaraki, Jeffrey E Lee, Suzanne E Shapiro, et al.
BMC Genomics|May 14, 2008
Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arraysHannah C Cheung, Keith A Baggerly, Spiridon Tsavachidis, et al.
Surgery|December 6, 2011
Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are importantPaxton V Dickson, Thereasa A Rich, Yan Xing, et al.
Hormones & Cancer|June 18, 2016
Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer CenterIoannis Christakis, Wei Qiu, Angelica M Silva Figueroa, et al.
Thyroid : Official Journal of the American Thyroid Association|July 21, 2005
RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumorsMaria A Kouvaraki, Suzanne E Shapiro, Nancy D Perrier, et al.
Pageof 7